Does Neurofeedback Actually Work?

“Does neurofeedback actually work?” is the right question to ask, and it deserves a better answer than most clinics give it.

The honest answer is that it depends almost entirely on what you are trying to help. The research is genuinely strong in a couple of places, thin in others, and for one of the most popular uses it is essentially null. Lumping all of that together into a single yes is how neurofeedback earned its skeptics.

So here is the evidence, condition by condition, including the parts that do not flatter us.

First, the one idea that explains everything else

Before any specific condition, there is one distinction worth understanding, because it explains why you will see wildly different claims about the same therapy.

It matters enormously what a study compares neurofeedback against.

Compare neurofeedback with a waitlist, or with no treatment at all, and effects tend to look large. Compare it against a sham, meaning a convincing fake version of the same training, and effects usually shrink. Sometimes they disappear entirely.

That gap is not unique to neurofeedback. It shows up across a lot of therapies, and it reflects something real: sitting down with a clinician, paying attention to your own brain, and expecting improvement genuinely does something. The sham comparison is how researchers separate the training itself from everything that surrounds it.

Keep that in mind for everything below, including the parts where the news is good.

Where the evidence is strongest: post-traumatic stress

This is the strongest ground neurofeedback has, and it is not what most practices lead with.

A 2024 systematic review and meta-analysis in Frontiers in Psychiatry pooled 17 studies covering 628 patients. On the clinician-administered PTSD scale, symptom scores improved with a standardized effect of 0.74 immediately after treatment and 0.80 at follow-up. The authors graded the quality of that evidence as high.

Research on neurofeedback for post-traumatic stress has shown meaningful reductions in symptom scores, with effects that held at follow-up. That is a real finding and it is why trauma is where we point people first.

Now the caveat, because it belongs in the same breath. Most of those studies did not blind participants or clinicians, so some of the effect is likely expectation. And when the same review looked only at the studies that used an active sham or yoked comparison, the effect on clinician-rated scores was 0.05, which is statistically indistinguishable from nothing. That subgroup was small, 86 patients across three studies, and one of them used only three training sessions, which is not a fair test of anything. But it is in the same paper as the headline number, and you deserve to know it is there.

The fair summary: the pooled evidence is the best in this field and was graded high quality, and the sham-controlled slice of it has not yet demonstrated a specific effect. Both of those are true at once.

Good evidence, weaker designs: anxiety

A 2022 meta-analysis in the Journal of Counseling & Development drew on 26 studies from 17 databases. Self-reported anxiety fell by close to a full standard deviation.

Across published studies of neurofeedback for anxiety, participants reported meaningful reductions in anxiety symptoms. The effect is large and it is consistent.

The caveat here is design rather than direction: 12 of those 26 studies had no control group at all, and the outcomes are self-reported rather than clinician-rated. That is weaker architecture than the PTSD literature sits on. The finding is worth taking seriously and it is not the same grade of proof.

Where the evidence is weakest: attention and ADHD

This is the one most people have heard about, and it is the one the evidence supports least. We would rather tell you that plainly than let you find out later.

In 2024, the European ADHD Guidelines Group published a systematic review and meta-analysis in JAMA Psychiatry pooling 38 randomized trials covering 2,472 people aged 5 to 40. When the analysis was restricted to reports from people who were probably unaware of who had received treatment, neurofeedback showed no significant improvement in total ADHD symptoms: a standardized effect of 0.04, with a confidence interval running from -0.10 to 0.18.

Their conclusion, in their own words: “Overall, neurofeedback did not appear to meaningfully benefit individuals with ADHD, clinically or neuropsychologically, at the group level.”

There are two smaller signals inside that same paper. Restricting to well-established protocols produced a small significant effect on total symptoms, 0.21. Processing speed showed 0.35. Both barely clear zero, both rest on a handful of trials, and the authors themselves warn that the processing-speed result may be inflated by overlapping samples. Building a marketing claim on those subgroups, against the paper’s own stated conclusion, is exactly the kind of cherry-picking that makes health advertising untrustworthy.

So we do not claim neurofeedback treats ADHD or reduces ADHD symptoms. What a brain map can do is show how your attention networks are actually working, in your own brain, which is a different and more modest thing. Neurofeedback is not a treatment for ADHD and is not a substitute for care from your prescriber.

Sleep, where the scoping is everything

Sleep splits into two questions with two different answers, and almost all of the confusion about neurofeedback and sleep comes from mixing them up.

If poor sleep is the whole problem, the evidence does not support neurofeedback. The decisive study is a 2017 double-blind, placebo-controlled trial in Brain, run by the same group whose earlier work had found positive results. Under proper blinding the specific effect disappeared. Sleep complaints improved in both the real and the sham groups, and objective sleep measures did not move. If disrupted sleep is your only concern, we will tell you honestly that cognitive behavioural therapy for insomnia has the stronger evidence, and we will help you find it.

When sleep problems come along with stress, anxiety, or trauma, the picture is different. In randomised trials where people trained with neurofeedback, participants reported better sleep quality than those given an inactive comparison, and the improvement was still there at follow-up months later. Note the word reported. The improvements that survive controlled testing are in how people rate their sleep, not in measured sleep architecture.

What “not FDA approved” actually means

You will see this used as an attack and as a dodge. It is neither, it is just a category fact.

Neurofeedback is a procedure, not a drug, so it is not something the FDA approves. The EEG equipment used in biofeedback is regulated as a Class II medical device and has been cleared through the 510(k) pathway for indications such as relaxation training. Clearance is not approval, and it attaches to the equipment rather than to neurofeedback as a therapy for a named condition.

Worth adding: where a neurofeedback-based technology has been cleared for post-traumatic stress, it was cleared as an adjunctive therapy, meaning alongside other treatment rather than instead of it. That framing matches how the research itself tends to describe neurofeedback’s role.

Neurofeedback is not FDA approved as a treatment for any specific condition, and it is not a cure.

So, does it work?

The most defensible answer we can give:

• Post-traumatic stress: the strongest evidence in the field, graded high quality, with an honest open question about how much survives sham comparison.
• Anxiety: consistent and large reported effects, on weaker study designs.
• Sleep alongside stress, anxiety, or trauma: supported for reported sleep quality. Sleep on its own: not supported.
• Attention and ADHD: not supported once raters are blinded. We do not make claims here.

If a clinic tells you neurofeedback works, full stop, for everything, they are either not reading the research or not telling you about it. The field is more interesting than that, and a lot more uneven.

What we actually do about it

We start with a qEEG brain map, because it is the one part of this that is measurement rather than promise. It shows how your own rhythms are behaving instead of assuming a generic pattern. Then you sit down with Dr. Cindy Morrey for a results review in plain language, and from there we build a training plan around what the map actually shows.

We work alongside your medical and mental health care, never in place of it, and we will tell you when the evidence points somewhere else. On trauma and anxiety we think the research earns your attention. On attention and focus we will show you your map and be straight about what the literature does and does not support.

If you want to start with the measurement rather than the claim, that is exactly what a brain map is for.

Sources

• Voigt JD, Mosier M, Tendler A. Systematic review and meta-analysis of neurofeedback and its effect on posttraumatic stress disorder. Frontiers in Psychiatry. 2024;15:1323485.
• Russo GM, Balkin RS, Lenz AS. A meta-analysis of neurofeedback for treating anxiety-spectrum disorders. Journal of Counseling & Development. 2022.
• Westwood SJ, Aggensteiner PM, Kaiser A, et al. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2024;82(2):118-129.
• Schabus M, Griessenberger H, Gnjezda MT, et al. Better than sham? A double-blind placebo-controlled neurofeedback study in primary insomnia. Brain. 2017;140(4):1041-1052.
• U.S. Food and Drug Administration, 21 CFR Part 882, Neurological Devices.